Freestone Grove Partners LP Ani Pharmaceuticals Inc Transaction History
Freestone Grove Partners LP
- $13.2 Trillion
- Q2 2025
A detailed history of Freestone Grove Partners LP transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Freestone Grove Partners LP holds 195,214 shares of ANIP stock, worth $18.6 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
195,214
Previous 3,997
4784.01%
Holding current value
$18.6 Million
Previous $268 Million
4660.0%
% of portfolio
0.1%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ANIP
# of Institutions
243Shares Held
20MCall Options Held
19.9KPut Options Held
12.8K-
Black Rock Inc. New York, NY2.66MShares$253 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.28MShares$122 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1MShares$95.6 Million0.03% of portfolio
-
Global Alpha Capital Management Ltd.862KShares$82.1 Million3.45% of portfolio
-
State Street Corp Boston, MA716KShares$68.2 Million0.0% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.66B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...